Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07650136 · ClinicalTrials.gov registry record
Method Comparison of Intelligent Fingerprinting Drug Screening System
A clinical trial, sponsored by Intelligent Bio Solutions.
- Recruiting
- Registry status
- 144
- Enrollment target
NCT07650136: Recruiting study, sponsored by Intelligent Bio Solutions.
NCT07650136 is a clinical trial that is actively recruiting participants, run by Intelligent Bio Solutions. The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07650136 is actively recruiting participants, sponsored by Intelligent Bio Solutions.
- RECRUITING
- Registry status
- 144 participants
- Enrollment target
Study Summary
Prospective, multi-site, open-label, single- or double-dose, randomized, multi-site performance evaluation of accuracy of the Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."
Primary Outcome
Sensitivity of the Intelligent Fingerprinting DSC 7-Plus Drug Screening Cartridge for Codeine
Interventions
- DEVICE Diagnostic Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2026-06-02 |
| Est. Completion | 2026-08-31 |
What NCT07650136 shows while recruiting
NCT07650136 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Diagnostic Test is the first listed.
NCT07650136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07650136 about?
NCT07650136 is a clinical study titled "Method Comparison of Intelligent Fingerprinting Drug Screening System". Prospective, multi-site, open-label, single- or double-dose, randomized, multi-site performance evaluation of accuracy of the Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."
What is the current status of trial NCT07650136?
This trial is currently recruiting. The enrollment target is 144 participants. The study started on 2026-06-02. Estimated completion is 2026-08-31.
What interventions are being tested in trial NCT07650136?
The interventions under investigation include: Diagnostic Test (DEVICE).
Who is sponsoring clinical trial NCT07650136?
This trial is sponsored by Intelligent Bio Solutions, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI